A 3-D virtual reality system to treat back pain was approved by the U.S. Food and Drug Administration on Tuesday. The EaseVRx system is a prescription device for at-home use that combines cognitive behavioral therapy and other behavioral methods to treat patients 18 and older with chronic lower back pain. “Millions of adults in the…  read on >  read on >

The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital in Boston. “Over the last…  read on >  read on >

The Biden administration plans to invest billions to partner with industry to expand the nation’s ability to produce coronavirus vaccines, ensure domestic supply and help poor nations in their vaccination efforts. The goal of the plan, to be announced Wednesday, is to produce at least 1 billion doses a year beginning in the second half…  read on >  read on >

WEDNESDAY, Nov. 17, 2021 (HealthDay News) – When young people are allowed to give their own consent for human papillomavirus (HPV) vaccines, vaccination rates are higher, new research shows. The new study suggests that allowing teens to consent without parental involvement could be an important strategy for boosting HPV vaccination rates. This consent is already…  read on >  read on >

Lung cancer survival rates in the United States continue to rise, but certain racial groups are still hit hard by the disease, the American Lung Association reports. Its fourth annual “State of Lung Cancer” report shows that the average five-year survival rate increased from 14.5% to nearly 24%, but it remains at 20% for people…  read on >  read on >